Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06027957. IPD Sharing: NO. Countries: 1. Publications: 0.
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02633111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01570049. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT05180097. IPD Sharing: NO. Countries: 2. Publications: 0.
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00005787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04609241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT05757466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00060385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00201669. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT02164006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06470438. IPD Sharing: YES. Countries: 7. Publications: 0.
Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk
ClinicalTrials.gov study NCT00849355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT00562978. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02662296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With
ClinicalTrials.gov study NCT02842931. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006695. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07192471. IPD Sharing: YES. Countries: 0. Publications: 0.
A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04232826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00184080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT06028373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.